Results 271 to 280 of about 659,274 (352)
Some of the next articles are maybe not open access.
Hospital Practice, 1989
Bone marrow transplantation for treatment of certain hematologic and nonhematologic diseases is rapidly becoming the treatment of choice for a large number of patients. Over 10,000 marrow transplants have been performed, and over 200 marrow transplant units currently exist.
E H, Romond +7 more
+7 more sources
Bone marrow transplantation for treatment of certain hematologic and nonhematologic diseases is rapidly becoming the treatment of choice for a large number of patients. Over 10,000 marrow transplants have been performed, and over 200 marrow transplant units currently exist.
E H, Romond +7 more
+7 more sources
Critical Care Nursing Clinics of North America, 1992
BMT is an effective treatment for certain malignant and nonmalignant conditions. The source of the marrow is autologous or allogeneic. An allogeneic donor can be an HLA-matched related or unrelated donor. The patient undergoes intense chemoradiotherapy to remove remaining malignant cells and obliterate the immune system, thus allowing growth of the new
D, Wujcik, S, Downs
openaire +4 more sources
BMT is an effective treatment for certain malignant and nonmalignant conditions. The source of the marrow is autologous or allogeneic. An allogeneic donor can be an HLA-matched related or unrelated donor. The patient undergoes intense chemoradiotherapy to remove remaining malignant cells and obliterate the immune system, thus allowing growth of the new
D, Wujcik, S, Downs
openaire +4 more sources
Best Practice & Research Clinical Rheumatology, 1999
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +2 more sources
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +2 more sources
Allogeneic Bone‐Marrow Transplantation
Immunological Reviews, 1983Allogeneic bone marrow transplantation now has an established place in the treatment of severe aplastic anemia and acute leukemia. Major problems to be overcome in transplantation in patients with aplastic anemia are marrow graft rejection and graft vs. host disease.
R, Storb, E D, Thomas
openaire +4 more sources
The Indian Journal of Pediatrics, 1993
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
The Nursing Clinics of North America, 1990
Learning Objectives: Fellows will learn how to work-up and subsequently manage patients admitted for bone marrow transplantation (BMT), peripheral blood stem cell transplantation (PBSCT), or their related complications.
Jeff Szer
semanticscholar +1 more source
Learning Objectives: Fellows will learn how to work-up and subsequently manage patients admitted for bone marrow transplantation (BMT), peripheral blood stem cell transplantation (PBSCT), or their related complications.
Jeff Szer
semanticscholar +1 more source
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
T, Franco, D A, Gould
openaire +2 more sources
Autologous Bone Marrow Transplantation
Critical Reviews in Clinical Laboratory Sciences, 1995Autologous bone marrow transplantation has become a very popular and successful treatment for many patients with lymphomas and other malignancies. The current indications, pretreatment regimes, and laboratory manipulations are discussed as well as the application of gene transfer to eliminate selected genetic diseases and detect disease relapse.
Leo J. McCarthy +5 more
openaire +2 more sources